Point72 Asia (Singapore)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-6,958
Closed -$362K – 1040
2025
Q2
$362K Sell
6,958
-1,789
-20% -$79.9K 0.06% 248
2025
Q1
$373K Buy
8,747
+6,743
+336% +$291K 0.1% 165
2024
Q4
$61.2K Buy
+2,004
New +$56.4K 0.02% 460
2024
Q3
– Sell
-2,464
Closed -$71.2K – 1112
2024
Q2
$71.2K Buy
+2,464
New +$57.4K 0.01% 565

Other funds holding GH

Point72 Asia (Singapore)'s GH Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Guardant Health (GH) in Q3 2025, closing a stake of 6,958 shares — an estimated $362K sold.

Point72 Asia (Singapore) first reported a position in GH in Q2 2024 and held it in 4 quarters. The position peaked at $373K in Q1 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 6,958 Guardant Health shares in Q3 2025, an estimated $362K.
  • Point72 Asia (Singapore) first reported a position in Guardant Health in Q2 2024 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Guardant Health position peaked at $373K in Q1 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.